391 related articles for article (PubMed ID: 7533133)
21. Anti-cytokine autoantibodies in experimental autoimmune neuritis in Lewis rats.
Zhu W; Mix E; Nennesmo I; Adem A; Zhu J
Exp Neurol; 2004 Dec; 190(2):486-94. PubMed ID: 15530887
[TBL] [Abstract][Full Text] [Related]
22. Conduction failure and nerve conduction slowing in experimental allergic neuritis induced by P2-specific T-cell lines.
Heininger K; Stoll G; Linington C; Toyka KV; Wekerle H
Ann Neurol; 1986 Jan; 19(1):44-9. PubMed ID: 2418761
[TBL] [Abstract][Full Text] [Related]
23. A complementary peptide vaccine that induces T cell anergy and prevents experimental allergic neuritis in Lewis rats.
Araga S; Kishimoto M; Doi S; Nakashima K
J Immunol; 1999 Jul; 163(1):476-82. PubMed ID: 10384151
[TBL] [Abstract][Full Text] [Related]
24. Neurophysiological changes in demyelinating and axonal forms of acute experimental autoimmune neuritis in the Lewis rat.
Taylor JM; Pollard JD
Muscle Nerve; 2003 Sep; 28(3):344-52. PubMed ID: 12929195
[TBL] [Abstract][Full Text] [Related]
25. Experimental allergic neuritis (EAN) as a model for the immune-mediated demyelinating neuropathies.
Hahn AF
Rev Neurol (Paris); 1996 May; 152(5):328-32. PubMed ID: 8881424
[TBL] [Abstract][Full Text] [Related]
26. MS-275, an histone deacetylase inhibitor, reduces the inflammatory reaction in rat experimental autoimmune neuritis.
Zhang ZY; Zhang Z; Schluesener HJ
Neuroscience; 2010 Aug; 169(1):370-7. PubMed ID: 20451583
[TBL] [Abstract][Full Text] [Related]
27. Compound A, a plant origin ligand of glucocorticoid receptors, increases regulatory T cells and M2 macrophages to attenuate experimental autoimmune neuritis with reduced side effects.
Zhang Z; Zhang ZY; Schluesener HJ
J Immunol; 2009 Sep; 183(5):3081-91. PubMed ID: 19675162
[TBL] [Abstract][Full Text] [Related]
28. Resolvin D1 Programs Inflammation Resolution by Increasing TGF-β Expression Induced by Dying Cell Clearance in Experimental Autoimmune Neuritis.
Luo B; Han F; Xu K; Wang J; Liu Z; Shen Z; Li J; Liu Y; Jiang M; Zhang ZY; Zhang Z
J Neurosci; 2016 Sep; 36(37):9590-603. PubMed ID: 27629711
[TBL] [Abstract][Full Text] [Related]
29. FTY720 ameliorates experimental autoimmune neuritis by inhibition of lymphocyte and monocyte infiltration into peripheral nerves.
Zhang Z; Zhang ZY; Fauser U; Schluesener HJ
Exp Neurol; 2008 Apr; 210(2):681-90. PubMed ID: 18261728
[TBL] [Abstract][Full Text] [Related]
30. Trapped in the epineurium: early entry into the endoneurium is restricted to neuritogenic T cells in experimental autoimmune neuritis.
Mausberg AK; Szepanowski F; Odoardi F; Flügel A; Kleinschnitz C; Stettner M; Kieseier BC
J Neuroinflammation; 2018 Aug; 15(1):217. PubMed ID: 30068351
[TBL] [Abstract][Full Text] [Related]
31. Treatment with P2 protein peptide 57-81 by nasal route is effective in Lewis rat experimental autoimmune neuritis.
Zou LP; Zhu J; Deng GM; Levi M; Wahren B; Diab A; Hillert J; Link H
J Neuroimmunol; 1998 May; 85(2):137-45. PubMed ID: 9630162
[TBL] [Abstract][Full Text] [Related]
32. Suppression of autoimmune neuritis in IFN-gamma receptor-deficient mice.
Zhu Y; Ljunggren HG; Mix E; Li HL; van der Meide P; Elhassan AM; Winblad B; Zhu J
Exp Neurol; 2001 Jun; 169(2):472-8. PubMed ID: 11358460
[TBL] [Abstract][Full Text] [Related]
33. Glial cell line-derived neurotrophic factor is expressed by inflammatory cells in the sciatic nerves of Lewis rats with experimental autoimmune neuritis.
Ahn M; Jin JK; Moon C; Matsumoto Y; Koh CS; Shin T
J Peripher Nerv Syst; 2010 Jun; 15(2):104-12. PubMed ID: 20626773
[TBL] [Abstract][Full Text] [Related]
34. Dynamics of production of MIP-1alpha, MCP-1 and MIP-2 and potential role of neutralization of these chemokines in the regulation of immune responses during experimental autoimmune neuritis in Lewis rats.
Zou LP; Pelidou SH; Abbas N; Deretzi G; Mix E; Schaltzbeerg M; Winblad B; Zhu J
J Neuroimmunol; 1999 Aug; 98(2):168-75. PubMed ID: 10430050
[TBL] [Abstract][Full Text] [Related]
35. A permanent rat T cell line that mediates experimental allergic neuritis in the Lewis rat in vivo.
Linington C; Izumo S; Suzuki M; Uyemura K; Meyermann R; Wekerle H
J Immunol; 1984 Oct; 133(4):1946-50. PubMed ID: 6206142
[TBL] [Abstract][Full Text] [Related]
36. CCR5 deficiency does not prevent P0 peptide 180-199 immunized mice from experimental autoimmune neuritis.
Duan RS; Chen Z; Bao L; Quezada HC; Nennesmo I; Winblad B; Zhu J
Neurobiol Dis; 2004 Aug; 16(3):630-7. PubMed ID: 15262275
[TBL] [Abstract][Full Text] [Related]
37. Nasal administration of recombinant rat IL-4 ameliorates ongoing experimental autoimmune neuritis and inhibits demyelination.
Deretzi G; Zou LP; Pelidou SH; Nennesmo I; Levi M; Wahren B; Mix E; Zhu J
J Autoimmun; 1999 Mar; 12(2):81-9. PubMed ID: 10047428
[TBL] [Abstract][Full Text] [Related]
38. The effects of monoamine reuptake inhibiting antidepressants in experimental allergic neuritis.
Zhu J; Mix E; Bengtsson BO; Link H
J Peripher Nerv Syst; 1997; 2(1):30-42. PubMed ID: 10975734
[TBL] [Abstract][Full Text] [Related]
39. T cell directed immunotherapy of inflammatory demyelination in the peripheral nervous system. Potent suppression of the effector phase of experimental autoimmune neuritis by anti-CD2 antibodies.
Jung S; Toyka K; Hartung HP
Brain; 1996 Aug; 119 ( Pt 4)():1079-90. PubMed ID: 8813272
[TBL] [Abstract][Full Text] [Related]
40. Modulation of experimental autoimmune neuritis in Lewis rats by oral application of myelin antigens.
Gaupp S; Hartung HP; Toyka K; Jung S
J Neuroimmunol; 1997 Nov; 79(2):129-37. PubMed ID: 9394785
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
